We are live on ! Find out more
PAVMW

PAVmed Inc. Warrant

Delisted

PAVMW was delisted on the 28th of January, 2022.

4 hedge funds and large institutions have $24K invested in PAVmed Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2,300% more capital invested

Capital invested by funds: $1K → $24K (+$23K)

100% more funds holding

Funds holding: 24 (+2)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VF
1
Virtu Financial
New York
$9K +$15.6K +20,911 New
WAM
2
Wolverine Asset Management
Illinois
$9K +$16.4K +21,973 +3,194%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$6K +$10.5K +14,078 New
UBS Group
4
UBS Group
Switzerland
-$22 -29 -4%

PAVMW Hedge Fund Activity: Q4 2020 in Review

4 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q4 2020, worth a combined $24K — up 2,300% from $1K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PAVMW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Wolverine Asset Management, adding an estimated $16.4K. The largest seller was UBS Group, cutting an estimated $22.

  • 4 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q4 2020, up from 2 in Q3 2020.
  • Funds reported $24K of PAVmed Inc. Warrant stock for Q4 2020, up 2,300% quarter-over-quarter.
  • 2 funds opened new PAVmed Inc. Warrant positions in Q4 2020 and 0 closed out, a net change of +2 holders.
  • The largest PAVmed Inc. Warrant buyer in Q4 2020 was Wolverine Asset Management, an estimated $16.4K added.
  • The largest PAVmed Inc. Warrant seller in Q4 2020 was UBS Group, an estimated $22 sold.

Based on aggregated 13F filings for Q4 2020.